Skip to main content
Matthew Tremblay, MD, Neurology, Livingston, NJ

Matthew Aaron Tremblay MD PhD

Neuroimmunology/Multiple Sclerosis


Multiple Sclerosis Specialist

Join to View Full Profile
  • 200 S Orange AveSte 124ALivingston, NJ 07039

  • Phone+1 973-322-0133

  • Fax+1 860-679-0131

Dr. Tremblay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a Neurologist specializing in Multiple Sclerosis and serve as Director of MS Research at RWJBarnabas Health since 2020.

    I received both my M.D. and Ph.D. from the Albert Einstein College of Medicine. I completed Neurology residency training at UCLA Medical Center and fellowship training at the UCSF Multiple Sclerosis Center. I served on the clinical Neurology faculty at UConn Health.
  • Meet 6 Physicians Now Seeing Patients at UConn Health - UConn Today

    Experts in multiple sclerosis, psychiatry, women's health, infectious diseases, and nephrology have joined the clinical faculty in recent months. Dr. Matthew Tr

    Profile: Dr. Matthew Tremblay

    Dr. Matthew Tremblay is a neurologist in the Department of Neurology at UConn Health. He specializes in the treatment of patients with multiple sclerosis.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Neuroimmunology & Multiple Sclerosis, 2015 - 2016
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2012 - 2015
  • Zucker School of Medicine at Hofstra/Northwell at Lenox Hill Hospital
    Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalInternship, Internal Medicine, 2011 - 2012
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicinePh.D, Department of Pathology, 2005 - 2011
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2011, MD
  • University of Rochester
    University of RochesterBS, Neuroscience, Cum Laude, 1999 - 2003

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • CA State Medical License
    CA State Medical License 2013 - 2019
  • CT State Medical License
    CT State Medical License 2016 - 2019
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Augustus S. Rose Resident Teaching Award UCLA, 2015
  • Student Prize for Excellence in Neurology American Academy of Neurology, 2011
  • Louis and Rachel Rudin Scholarship Albert Einstein College of Medicine, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain.  
    Schlatterer SD, Tremblay MA, Acker CM, Davies P., Journal of Alzheimer's Disease
  • Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.  
    Tremblay MA, Acker CM, Davies P., Journal of Alzheimers Disease
  • Epilepsy and Neurogenesis.  
    Tremblay MA, Journal of Undergraduate Research - University of Rochester 2: 20-26

Books/Book Chapters

Abstracts/Posters

  • Co-morbid Lymphomatosis Cerebri and testicular lymphoma in a case of rapidly progressive dementia
    Tremblay MA, Ashley MJ, Vinters HV, Guo M, American Academy of Neurology, Washington, DC
  • Neurodegeneration as a consequence of expression of active c-abl in the adult mouse brain.
    Sarah D. Schlatterer, Matthew A. Tremblay, Christopher M. Acker, and Peter Davies, Ph.D, The International Conference on Alzheimer’s Disease and Related Disorders
  • Abl2 phosphorylates three tyrosine residues of microtubule-associated protein tau.
    Matthew A. Tremblay and Peter Davies, Ph.D, Society for Neuroscience Annual Meeting
  • Join now to see all

Authored Content

  • Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple SclerosisDecember 2023

Press Mentions

  • Expert Discusses First and Only Drug Approved for Progressive Multiple Sclerosis
    Expert Discusses First and Only Drug Approved for Progressive Multiple SclerosisMarch 31st, 2017
  • Sick Stem Cells Point to Better MS Drugs
    Sick Stem Cells Point to Better MS DrugsMarch 29th, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: